ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Connecticut » Infectious Disease

Top Infectious Disease Prescribers in Connecticut

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DOUGLAS FINCH M.D.

Infectious Disease

4,804

$288K

135
116 are 65+

24%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 49%

$60
Average prescription price

Avg: $315

ALEJANDRO MURCIA M.D.

Infectious Disease

4,773

$296K

329
280 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 49%

$62
Average prescription price

Avg: $315

CLIFFORD STIRBA MD

Infectious Disease

4,636

$874K

144
72 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 49%

$189
Average prescription price

Avg: $315

JONATHAN TRESS M.D.

Infectious Disease

4,377

$919K

145
105 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 49%

$210
Average prescription price

Avg: $315

ZANE SAUL M.D.

Infectious Disease

4,100

$1.19M

247
135 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 49%

$289
Average prescription price

Avg: $315

GARY BLICK MD

Infectious Disease

3,082

$1.84M

74
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

73%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 49%

$598
Average prescription price

Avg: $315

EUGENE CICCONE M.D.

Infectious Disease

2,925

$581K

125
62 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 49%

$199
Average prescription price

Avg: $315

NESRINE RIZK MD

Infectious Disease

2,126

$646K

125
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 49%

$304
Average prescription price

Avg: $315

SHARJEEL AHMAD M.D.

Infectious Disease

1,975

$413K

154
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 49%

$209
Average prescription price

Avg: $315

JACK ROSS M.D.

Infectious Disease

1,806

$730K

80
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 49%

$404
Average prescription price

Avg: $315

GORAN MILJKOVIC M.D.

Infectious Disease

1,681

$264K

162
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 49%

$157
Average prescription price

Avg: $315

SAILAJA PUTTAGUNTA M.D.

Infectious Disease

1,469

$365K

19
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 49%

$249
Average prescription price

Avg: $315

STEVEN ARONIN MD

Infectious Disease

1,447

$747K

73
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 49%

$516
Average prescription price

Avg: $315

MICHAEL LAWLOR MD

Infectious Disease

1,440

$649K

201
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 49%

$451
Average prescription price

Avg: $315

JO-ANNE PASSALACQUA M.D.

Infectious Disease

1,410

$357K

136
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 49%

$253
Average prescription price

Avg: $315

NINA CARLEY MD

Infectious Disease

1,317

$287K

145
118 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 49%

$218
Average prescription price

Avg: $315

ELLEN NEUHAUS MD

Infectious Disease

1,306

$980K

41
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

82%
prescriptions for brand name drugs

Avg: 49%

$750
Average prescription price

Avg: $315

ROBERT LEVITZ M.D.

Infectious Disease

1,181

$560K

120
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 49%

$475
Average prescription price

Avg: $315

ARTHUR YEE M.D.

Infectious Disease

1,152

$106K

136
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 49%

$92
Average prescription price

Avg: $315

MICHAEL VIRATA MD

Infectious Disease

1,120

$438K

79
11 are 65+

27%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 49%

$391
Average prescription price

Avg: $315

JOSEPH GADBAW M.D.

Infectious Disease

1,098

$748K

83
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 49%

$681
Average prescription price

Avg: $315

MERCEDITAS VILLANUEVA MD

Infectious Disease

1,087

$398K

50
0 are 65+

24%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 49%

$366
Average prescription price

Avg: $315

LYDIA AOUN-BARAKAT MD

Infectious Disease

1,036

$397K

60
0 are 65+

35%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 49%

$384
Average prescription price

Avg: $315

GAVIN MCLEOD MD

Infectious Disease

1,034

$569K

65
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 49%

$550
Average prescription price

Avg: $315

GARY SCHLEITER M.D.

Infectious Disease

967

$333K

103
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 49%

$344
Average prescription price

Avg: $315

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank